Paul A Davies

This study shows that activating KCC2 improves neurophysiological and behavioral symptoms in female Rett syndrome mice.

This study shows that activating KCC2 during development reduces seizures, cognitive, and behavioral issues in adult CDKL5-deficient mice, but adult treatment is less effective.

This study shows that KCC2 is essential for the survival of mature neurons but not for their development or structural formation.

This study isolates and characterizes multi-protein complexes containing Kcc2 from brain plasma membranes, identifying novel interactors and phosphorylation sites that may regulate its function.

The paper identifies KCC2 as a convergence point for ASD/Epi risk genes through proteomic analysis and shows its interaction with FMRP targets and effects on GABAergic inhibition.